Several analysts have recently updated their ratings and price targets for Lear (NYSE: LEA): 10/9/2026 – Lear had its price target lowered by Barclays PLC from $155.00 to $145.00. They now have an “equal weight” rating on the stock. 10/7/2026 – Lear had its price target lowered by UBS Group AG from $141.00 to $132.00. […]

Several brokerages have updated their recommendations and price targets on shares of Sunrun (NASDAQ: RUN) in the last few weeks: 10/9/2026 – Sunrun had its “hold” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $7.00 price target on the stock. 10/9/2026 – Sunrun had its price target lowered by Barclays PLC from […]

A number of firms have modified their ratings and price targets on shares of Williams Companies (NYSE: WMB) recently: 10/1/2026 – Williams Companies is now covered by Barclays PLC. They set an “overweight” rating and a $82.00 price target on the stock. 10/1/2026 – Williams Companies had its “overweight” rating reaffirmed by Barclays PLC. They […]

Beta Bionics (NASDAQ: BBNX) recently received a number of ratings updates from brokerages and research firms: 10/6/2026 – Beta Bionics is now covered by Barclays PLC. They set an “overweight” rating and a $30.00 price target on the stock. 10/6/2026 – Beta Bionics was upgraded by Barclays PLC to “strong-buy”. 9/24/2026 – Beta Bionics had […]

Several analysts have recently updated their ratings and price targets for LB Pharmaceuticals (NASDAQ: LBRX): 10/9/2026 – LB Pharmaceuticals is now covered by Canaccord Genuity Group Inc.. They set a “buy” rating and a $65.00 price target on the stock. 10/6/2026 – LB Pharmaceuticals is now covered by Guggenheim. They set a “buy” rating and […]

A number of firms have modified their ratings and price targets on shares of Viper Energy (NASDAQ: VNOM) recently: 10/9/2026 – Viper Energy had its “buy” rating reaffirmed by Citigroup Inc.. 10/9/2026 – Viper Energy had its price target raised by Royal Bank Of Canada from $55.00 to $57.00. They now have an “outperform” rating […]

Several analysts have recently updated their ratings and price targets for Caribou Biosciences (NASDAQ: CRBU): 10/8/2026 – Caribou Biosciences was downgraded by HC Wainwright from “buy” to “neutral”. 10/7/2026 – Caribou Biosciences was downgraded by Royal Bank Of Canada from “outperform” to “sector perform”. They now have a $1.00 price target on the stock. 10/7/2026 […]

Solstice Advanced Mat (NASDAQ: SOLS) has recently received a number of price target changes and ratings updates: 10/7/2026 – Solstice Advanced Mat is now covered by Seaport Research Partners. They set a “buy” rating and a $80.00 price target on the stock. 10/5/2026 – Solstice Advanced Mat had its price target lowered by UBS Group […]

A number of firms have modified their ratings and price targets on shares of Illinois Tool Works (NYSE: ITW) recently: 10/9/2026 – Illinois Tool Works was given a new $277.00 price target by UBS Group AG. 10/9/2026 – Illinois Tool Works was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have […]

Investment Analysts’ price target changes for Friday, October 9th: Aritzia (TSE:ATZ) had its price target raised by Ventum Capital from C$146.00 to C$160.00. The firm currently has a neutral rating on the stock. Aritzia (TSE:ATZ) had its price target reduced by TD from C$200.00 to C$175.00. TD currently has a buy rating on the stock. […]